Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539370 · ClinicalTrials.gov registry record
Human Samples and Data Repository
A clinical trial, sponsored by National Eye Institute (NEI).
- Terminated
- Registry status
- 1,862
- Enrollment target
NCT00539370: Clinical Trial study, sponsored by National Eye Institute (NEI).
NCT00539370 is a clinical trial that was terminated before completion, run by National Eye Institute (NEI). The registered enrollment target is 1,862 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00539370 was terminated before completion, sponsored by National Eye Institute (NEI).
- TERMINATED
- Registry status
- 1,862 participants
- Enrollment target
Study Summary
This protocol will enable IRB (institutional review board) review of proposed research using human samples and data collected under the terminated NIH studies 04-EI-0065 and 96-EI-0096. Data and samples may include demographic and personal health information, psychological or psychiatric testing, blood, urine, CSF or other body fluids or tissues and results of medical and physiological evaluation and medical imaging. Data and sample analyses are limited to those approved under the original protocols unless additional specific institutional review board approval is obtained.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,862 participants |
| Start Date | 2007-08-29 |
| Est. Completion | 2022-08-19 |
Why NCT00539370 stopped before completion
NCT00539370 is an observational study that tracks outcomes without assigning an intervention. Its 1,862 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00539370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00539370 about?
NCT00539370 is a clinical study titled "Human Samples and Data Repository". This protocol will enable IRB (institutional review board) review of proposed research using human samples and data collected under the terminated NIH studies 04-EI-0065 and 96-EI-0096. Data and samples may include demographic and personal health information, psychological or psychiatric testing, bl...
What is the current status of trial NCT00539370?
This trial is currently terminated. The enrollment target is 1,862 participants. The study started on 2007-08-29. Estimated completion is 2022-08-19.
Who is sponsoring clinical trial NCT00539370?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07203313 · 1,872 participants · NA
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT05675410 · 1,875 participants · Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI